248594-19-6 Usage
General Description
Erlotinib mesylate is a cancer medication that belongs to the class of drugs known as kinase inhibitors. It works by blocking the action of a certain protein in the body, which may help slow down or stop the growth of cancer cells. Erlotinib mesylate is commonly used to treat certain types of lung cancer, pancreatic cancer, and other cancers. It is often prescribed when other chemotherapy options have not been effective. This medication is usually taken by mouth, and its use may be associated with various side effects, including diarrhea, skin rash, and fatigue. It is important for patients to discuss the potential benefits and risks of taking erlotinib mesylate with their healthcare provider before starting this treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 248594-19-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,8,5,9 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 248594-19:
(8*2)+(7*4)+(6*8)+(5*5)+(4*9)+(3*4)+(2*1)+(1*9)=176
176 % 10 = 6
So 248594-19-6 is a valid CAS Registry Number.
248594-19-6Relevant articles and documents
Processes and intermediates for preparing anti-cancer compounds
-
, (2008/06/13)
The present invention relates to methods and intermediates for preparing compounds of the formula 1 and the pharmaceutically acceptable salts and solvates thereof, as well as structurally related compounds, wherein R1, R2and R15are as defined herein. The foregoing compounds are useful in the treatment of hyperproliferative disorders, such as cancers, in mammals.
